Literature DB >> 20501609

A T(h)17-polarized cell population that has infiltrated the lung requires cells that convert to IFN-{gamma} production in order to induce airway hyperresponsiveness.

Shigeru Ashino1, Daiko Wakita, Yasuo Shiohama, Yoichiro Iwakura, Kenji Chamoto, Takayuki Ohkuri, Hidemitsu Kitamura, Takashi Nishimura.   

Abstract

Adoptive cell transfer of an ovalbumin (OVA)-specific T(h)17-polarized cell population from transgenic DO11.10 mice into BALB/c mice followed by OVA inhalation caused airway hyperresponsiveness (AHR) with severe neutrophilia. The transferred T(h)17 cell population-previously polarized in vitro with IL-6, transforming growth factor-beta and IL-23-contained negligible numbers of IFN-gamma-producing cells; however, during T(h)17-cell-dependent airway inflammation, significant numbers of IFN-gamma-producing cells-including cells producing both IL-17 and IFN-gamma and cells producing only IFN-gamma-were detected in the lung in addition to cells producing only IL-17. Using T(h)17-polarized cell populations derived from IL-17(-/-) or IFN-gamma(-/-) mice, it was demonstrated that IL-17 is essential for inducing neutrophilic airway inflammation and that IFN-gamma is required for the AHR elevation. IFN-gamma appeared to be derived from cells producing both IL-17 and IFN-gamma and/or from cells producing only IFN-gamma, which were converted from the transferred T(h)17-polarized cell population. We also found that mAbs that neutralize IL-12 significantly suppressed the conversion of the T(h)17-polarized cell population toward IFN-gamma producers in the lung; concomitantly, with this decreased conversion, IL-12 neutralization also attenuated the AHR elevation in the lung. IL-12-dependent conversion of the transferred T(h)17-polarized cell population into IFN-gamma producers in the lung thus appeared to be a crucial process for inducing AHR elevation in T(h)17-cell-dependent airway inflammation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20501609     DOI: 10.1093/intimm/dxq034

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  6 in total

1.  Forkhead box protein 3 demethylation is associated with tolerance induction in peanut-induced intestinal allergy.

Authors:  Meiqin Wang; Ivana V Yang; Elizabeth J Davidson; Anthony Joetham; Katsuyuki Takeda; Brian P O'Connor; Erwin W Gelfand
Journal:  J Allergy Clin Immunol       Date:  2017-05-04       Impact factor: 10.793

2.  T(H)17 cells mediate pulmonary collateral priming.

Authors:  Melanie Albrecht; Hui-Chen Chen; Paula Preston-Hurlburt; Patricia Ranney; Heinz-Gerd Hoymann; Joachim Maxeiner; Valérie Staudt; Christian Taube; H Kim Bottomly; Anna-Maria Dittrich
Journal:  J Allergy Clin Immunol       Date:  2011-04-02       Impact factor: 10.793

3.  Janus kinase 1/3 signaling pathways are key initiators of TH2 differentiation and lung allergic responses.

Authors:  Shigeru Ashino; Katsuyuki Takeda; Hui Li; Vanessa Taylor; Anthony Joetham; Polly R Pine; Erwin W Gelfand
Journal:  J Allergy Clin Immunol       Date:  2013-12-22       Impact factor: 10.793

4.  The steroidogenic enzyme Cyp11a1 is essential for development of peanut-induced intestinal anaphylaxis.

Authors:  Meiqin Wang; Julita Ramirez; Junyan Han; Yi Jia; Joanne Domenico; Max A Seibold; James R Hagman; Erwin W Gelfand
Journal:  J Allergy Clin Immunol       Date:  2013-07-16       Impact factor: 10.793

5.  Inhibition of Pim1 kinase prevents peanut allergy by enhancing Runx3 expression and suppressing T(H)2 and T(H)17 T-cell differentiation.

Authors:  Meiqin Wang; Masakazu Okamoto; Joanne Domenico; Junyan Han; Shigeru Ashino; Yoo Seob Shin; Erwin W Gelfand
Journal:  J Allergy Clin Immunol       Date:  2012-09-01       Impact factor: 10.793

6.  RORγt inhibitors block both IL-17 and IL-22 conferring a potential advantage over anti-IL-17 alone to treat severe asthma.

Authors:  David Lamb; Dorothy De Sousa; Karsten Quast; Katrin Fundel-Clemens; Jonas S Erjefält; Caroline Sandén; Hans Jürgen Hoffmann; Marc Kästle; Ramona Schmid; Kevin Menden; Denis Delic
Journal:  Respir Res       Date:  2021-05-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.